This study is currently not recruiting participants.

Vitek 2 and Vitek 2 Compact GN22 Antimicrobial Susceptibility Tests PRG0028/B2898 GN22 Development and Clinical Trial Protocol BMX.1.020042

Study on Antimicrobial Testing with Investigational Card

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to collect clinical isolate card and reference data to demonstrate the effectiveness of the GN22 card for antimicrobial testing when used on the Vitek2 and Vitek2 compact systems.

Detailed description of study

The purpose of this study is to collect clinical isolate card and reference data to demonstrate the effectiveness of the GN22 card for antimicrobial testing when used on the Vitek2 and Vitek2 compact systems.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: bacterial infection
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate how well the GN22 card works for testing bacteria against antibiotics. It uses machines called Vitek2 and Vitek2 compact systems to see if the card can accurately test how bacteria respond to different antibiotics.

Participants in the study will have their samples tested using the GN22 card. This process involves comparing the card's results to known data to ensure its accuracy in identifying bacterial resistance to antibiotics.

  • Who can participate: Participants will be those whose samples are available for testing.
  • Study details: Participants will have their samples analyzed using the investigational card, which is part of a system that tests bacteria against antibiotics.
Updated on 19 Feb 2024. Study ID: 1806874773

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team